A Study to Assess Genetics, Risk and Education of Mammography


About this study

The purpose of this study is to to evaluate the integration of cancer genetic testing into a mammography practice aimed toward women at intermediate- to-high lifetime risk of breast cancer. If successful, this will provide an opportunity for cancer risk stratification and individualized screening.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women participating in IRB:18-010601.
  • Aged 35 and over.
  • Having a negative routine mammogram within 3 months.
  • Qualifies as intermediate or high-risk (> 15% lifetime risk of breast cancer as defined by IBIS version 8).
  • Has an active email address for survey completion.

Exclusion Criteria: 

  • Not participating in the CEDM pilot.
  • Known genetic cancer syndrome with test results available. for review in Mayo EMR.
  • Known breast cancer.
  • Unable to understand or sign informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Niloy Jewel Samadder, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information


Publications are currently not available

Mayo Clinic Footer